Skip to main content
SpringerLink
Log in

Does denosumab improve low BMD in postmenopausal women?

  • Practice Point
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338: 736–746

    Article  CAS  Google Scholar 

  2. Bone HG et al. (2004) Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350: 1189–1199

    Article  CAS  Google Scholar 

  3. Tashjian AH Jr et al. (2006) Teriparatide [human PTH (1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 21: 354–365

    Article  CAS  Google Scholar 

  4. Boyle WJ et al. (2003) Osteoclast differentiation and activation. Nature 423: 337–342

    Article  CAS  Google Scholar 

  5. Kostenuik PJ (2005) Osteoprotegrin and RANKL regulate bone resorption, density, geometry, and strength. Curr Opin Pharmacol 5: 618–625

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Marie Lofthouse, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Director of the Bone Program and Professor of Medicine at the University of Chicago Pritzker School of Medicine, Chicago, IL, USA

    Murray J Favus

Authors
  1. Murray J Favus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Murray J Favus.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Favus, M. Does denosumab improve low BMD in postmenopausal women?. Nat Rev Endocrinol 2, 600–601 (2006). https://doi.org/10.1038/ncpendmet0328

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0328

  • Springer Nature Limited

This article is cited by

Search

Navigation